Anaplastic lymphoma kinase gene rearrangement predicts better prognosis in NSCLC patients: A meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anaplastic lymphoma kinase gene rearrangement predicts better prognosis in NSCLC patients: A meta-analysis

Published:2017-10 Issue: Volume:112 Page:1-9
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Wang Zili,Yang Haitao,Luo Shuimei,Liu Bo,Zhang Nianhai,Li Lina,Zhou Sijing,Shen Ruifen,Xie Xianhe

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference34 articles.

1. Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling;Wang;Carcinogenesis,2013

2. Cancer statistics, 2016;Siegel;CA,2016

3. Erlotinib in lung cancer – molecular and clinical predictors of outcome;Tsao;New Engl. J. Med.,2005

4. Non-small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology;Ettinger;J. Natl. Compr. Cancer Netw. JNCCN,2017

5. EGFR mutations and clinical outcomes of chemotherapy for advanced non-small cell lung cancer: a meta-analysis;Zhang;Lung Cancer,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of electrochemical immunosensor for quantitative detection of non-small cell lung cancer (NSCLC) biomaker YES1;Biosensors and Bioelectronics: X;2023-09

2. VAV3 in human cancers: Mechanism and clinical implication;Pathology - Research and Practice;2023-08

3. Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands;Scientific Reports;2023-02-09

4. Early-stage ALK-positive lung cancer: a narrative review;Translational Lung Cancer Research;2023-02

5. Prophylaxis strategies containing high dose intravenous methotrexate on preventing CNS relapse for patients with diffuse large B-cell lymphoma at intermediate to high risk: A study based on 12 cohorts in the rituximab era;International Immunopharmacology;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3